DEK oncogene (DEK) is a gene that encodes a protein involved in chromatin organization, DNA damage response signaling, and DNA repair (Kavanaugh et al.
2011; UniProt 2013).
In cancer, rearrangements involving DEK have been observed in AML. Its role is also being
investigated in breast, head and neck, cervical, and bladder cancer, as well as in CLL.
Nucleoporin 214kDa (NUP214) is a gene that
encodes a component of the nuclear core complex, a structure that regulates flow of material
between the nucleus and cytoplasm (Gene 2013). In cancer,
rearrangements involving DEK have been observed in AML, MDS, and ALL. NUP214 is also known
The DEK-NUP214 fusion has been primarily observed in acute myeloid leukemia.
Seegmiller, A., Jagasia, M. 2015.
My Cancer Genome
(Updated December 2015)
December 4, 2015
Disclaimer: The information presented at padiracinnovation.org is compiled from sources
believed to be reliable. Extensive efforts have been made to make this information as accurate and as
up-to-date as possible. However, the accuracy and completeness of this information cannot be guaranteed.
Despite our best efforts, this information may contain typographical errors and omissions. The contents
are to be used only as a guide, and health care providers should employ sound clinical judgment in
interpreting this information for individual patient care.